| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.45 | 2e-11 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.006 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |